Search

Author/Creator Cohen, Adam F.

3. Antisense‐mediated reduction of proprotein convertase subtilisin/kexin type 9 (PCSK9): a first‐in‐human randomized, placebo‐controlled trial. (24th October 2015)

Authors:
van Poelgeest, Eveline P.; Hodges, Michael R.; Moerland, Matthijs; Tessier, Yann; Levin, Arthur A.; Persson, Robert; Lindholm, Marie W.; Dumong Erichsen, Kamille; Ørum, Henrik; Cohen, Adam F.; Burggraaf, Jacobus
Journal:
British journal of clinical pharmacology
Issue:
Volume 80:Number 6(2015:Dec.)
Page Start:
1350
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

8. Clinical validation of digital biomarkers for paediatric patients with asthma and cystic fibrosis: potential for clinical trials and clinical care. Issue 6 (9th June 2022)

Authors:
Kruizinga, Matthijs D.; Essers, Esmée; Stuurman, Frederik E.; Yavuz, Yalçin; de Kam, Marieke L.; Zhuparris, Ahnjili; Janssens, Hettie M.; Groothuis, Iris; Sprij, Arwen J.; Nuijsink, Marianne; Cohen, Adam F.; Driessen, Gertjan J.A.
Journal:
European respiratory journal
Issue:
Volume 59:Issue 6(2022)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

9. COVID‐19 vaccines: the importance of transparency and fact‐based education. Issue 11 (14th October 2020)

Authors:
Cohen, Adam F.; van Gerven, Joop; Burgos, Juan Garcia; de Boer, Anthonius; Foucher, Ron A. M.; Flore, H.; Teitelbaum, Zvi; van Eden, Willem; Webb, Andrew; Cremers, Serge
Journal:
British journal of clinical pharmacology
Issue:
Volume 86:Issue 11(2020)
Page Start:
2107
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗